ArticleiScience2021

The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory.

Sonia Ndeupen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.